South Texas Accelerated Research Therapeutics:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:South Texas Accelerated Research Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10926
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
South Texas Accelerated Research Therapeutics (START) accelerates the development of novel anticancer agents that improves personalized and clinical care for cancer patients. The company offers preclinical and clinical research services which include pharmacokinetics, in vivo and in vitro services; regulatory affairs support; drug investigation studies; preclinical models and assays to accelerate oncology drug development; and others. It also conducts phase I medical oncology programs using innovative information technology infrastructure for rapid clinical trials, as well as patient tumor model program to accelerate drug discovery and development for the treatment of cancer. The company has operations with offices in the China and Spain. START is headquartered in San Antonio, Texas.

South Texas Accelerated Research Therapeutics – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
South Texas Accelerated Research Therapeutics, Medical Devices Deals, 2012 to YTD 2018 9
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
South Texas Accelerated Research Therapeutics and Sarah Cannon Research Institute Enter into Partership 11
SA1KCGP, WuXi NextCODE and START Enter into Partnership 12
Denovo Sciences Enters into Research Agreement with South Texas Accelerated Research Therapeutics 13
South Texas Accelerated Research Therapeutics – Key Competitors 14
South Texas Accelerated Research Therapeutics – Key Employees 15
South Texas Accelerated Research Therapeutics – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Key Facts 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
South Texas Accelerated Research Therapeutics, Deals By Therapy Area, 2012 to YTD 2018 8
South Texas Accelerated Research Therapeutics, Medical Devices Deals, 2012 to YTD 2018 9
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
South Texas Accelerated Research Therapeutics and Sarah Cannon Research Institute Enter into Partership 11
SA1KCGP, WuXi NextCODE and START Enter into Partnership 12
Denovo Sciences Enters into Research Agreement with South Texas Accelerated Research Therapeutics 13
South Texas Accelerated Research Therapeutics, Key Competitors 14
South Texas Accelerated Research Therapeutics, Key Employees 15
South Texas Accelerated Research Therapeutics, Other Locations 16

List of Figures
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
South Texas Accelerated Research Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
South Texas Accelerated Research Therapeutics, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[South Texas Accelerated Research Therapeutics:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ezra Holdings Ltd-石油・ガス分野:企業M&A・提携分析
    Summary Ezra Holdings Limited (Ezra Holdings) is an offshore contractor and provider of integrated offshore solutions to the oil and gas industry. The group's service portfolio consists of subsea construction and maintenance, drilling support, towing and mooring, pipe and cable operations, high spee …
  • Dong Wha Pharma Co Ltd (000020):企業の財務・戦略的SWOT分析
    Summary Dong Wha Pharma Co Ltd (Dongwha Pharm) is a pharmaceutical company that offers generic products. The company offers ethical drugs, over-the-counter products, cosmetics, health foods, medical devices, and food and drinks. Its products comprise clzapine tablets, valaboom, aripico tablets, intr …
  • SKC Co., Ltd. (011790):企業の財務・戦略的SWOT分析
    SKC Co., Ltd. (011790) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Diamond Offshore Drilling Inc (DO):企業の財務・戦略的SWOT分析
    Diamond Offshore Drilling Inc (DO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Kvaerner ASA (KVAER):石油・ガス:M&Aディール及び事業提携情報
    Summary Kvaerner ASA (Kvaerner) is a provider of engineering, procurement and construction (EPC) services to steel substructures, topsides, concrete structures and onshore facilities. Its service portfolio includes project management, front-end engineering and design, detailed engineering, construct …
  • OAO Gazprom:企業の戦略・SWOT・財務情報
    OAO Gazprom - Strategy, SWOT and Corporate Finance Report Summary OAO Gazprom - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • FRESHNESS, CO., LTD:企業の戦略・SWOT・財務情報
    FRESHNESS, CO., LTD - Strategy, SWOT and Corporate Finance Report Summary FRESHNESS, CO., LTD - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Enterome Bioscience SA:企業の製品パイプライン分析2018
    Summary Enterome Bioscience SA (Enterome) is a drug development company that develops medical tests, and companion diagnostics to develop the management of microbiome-related diseases. The company develops medical tests based on its metagenotype technology platform that helps to identify microbiome- …
  • McAfee, Inc.:企業の戦略的SWOT分析
    McAfee, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Aluminum Corporation of China Ltd:企業の戦略・SWOT・財務情報
    Aluminum Corporation of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Aluminum Corporation of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Sutter Health:製薬・医療:M&Aディール及び事業提携情報
    Summary Sutter Health (Sutter Health) is a non-profit healthcare service provider, which provides health care service through its hospitals, ambulatory surgery centers, cardiac centers, cancer centers, rehabilitation centers and others. It serves communities across Northern California- in the San Fr …
  • Prinzhorn Holding Gmbh
    Prinzhorn Holding Gmbh - Strategy, SWOT and Corporate Finance Report Summary Prinzhorn Holding Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • SK Holdings Co Ltd (034730):企業の財務・戦略的SWOT分析
    SK Holdings Co Ltd (034730) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Zosano Pharma Corp (ZSAN):企業の財務・戦略的SWOT分析
    Summary Zosano Pharma Corp (Zosano Pharma), formerly ZP Holdings Inc, is a clinical stage biopharmaceutical company that develops proprietary transdermal delivery system. The company develops a transdermal microneedle patch system to deliver its drug formulations through the skin for the treatment o …
  • The Boeing Company:企業の戦略・SWOT・財務情報
    The Boeing Company - Strategy, SWOT and Corporate Finance Report Summary The Boeing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Foundation Medicine, Inc.:企業のM&A・事業提携・投資動向
    Foundation Medicine, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Foundation Medicine, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • H. Butting GmbH & Co KG:企業の戦略・SWOT・財務情報
    H. Butting GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary H. Butting GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Steel Authority of India Ltd:戦略・SWOT・企業財務分析
    Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report Summary Steel Authority of India Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Reynard Corporation:企業の戦略・SWOT・財務情報
    Reynard Corporation - Strategy, SWOT and Corporate Finance Report Summary Reynard Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • VytronUS Inc:医療機器:M&Aディール及び事業提携情報
    Summary VytronUS Inc (VytronUS), formerly CardionUS Inc, is an independent clinical stage medical device company that develops technologies for the treatment atrial fibrillation and other cardiac arrhythmias. The company is developing a catheter-based imaging and ablation platform based on low-inten …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆